Considering that obesity, T2D, and NAFLD share insulin resistance as a common pathophysiologic mechanism20 and that the dominant expression of betatrophin is in human liver12, we hypothesized that circulating betatrophin levels might be elevated in subjects with NAFLD. The gene discussed is ANGPTL8; the disease is obesity due to melanocortin 4 receptor deficiency.